Figure 3 | Scientific Reports

Figure 3

From: Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes

Figure 3

Neoantigen comparison between LN-negative and LN-positive breast cancer. (A) The boxplot of the number of neoantigen peptides. (B) The boxplot shows the number of neoantigen-related proteins. The graph shows that neoantigen burdens are significantly different between LN-negative and LN-positive groups by the Wilcox rank sum test (p < 0.005). (C) Network of neoantigen origin proteins specified in LN-positive breast cancer samples. LN-positive specific neoantigen origin proteins include the MAPK family, the BCL family, TRIM65, and CD98.

Back to article page